drugset / Trial / NCT03266991
Treatment of Latent Tuberculosis in Socially Marginalised Citizens
RandomizedParallel-groupOpen-labelTreatment
Summary
An open-label, randomised controlled trial comparing compliance to treatment for latent tuberculosis infection in socially marginalised citizens. Participants will be randomized to either daily isoniazid for 6 months or weekly rifapentine and isoniazid as directly observed therapy for twelve weeks.
Timeline
- Start
- 2017-10-27
- Primary completion
- 2023-02-09
- Completion
- 2023-02-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoniazid | Small molecule | — | — |
| Subject | Rifapentine | Small molecule | — | — |
Indications
No indication recorded.